Author

Matthew Bogyo

Queen's University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:imaging· 1 Organism:mouse· 1 Organism:plant (other)· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Abby Mocherniak· 1 shared Badr SokratiD· 1 shared Brian L. SchmidtiD· 1 shared Chloe J. PeachiD· 1 shared Christine Lehmann· 1 shared Dane D. JenseniD· 1 shared Divya BhansaliiD· 1 shared Edgar Deu· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Abby Mocherniak

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanomedicines targeting signaling of protease-activated receptor 2 in organelles provide sustained analgesia

Shavonne L. Teng, Rocco Latorre, Divya Bhansali, Parker K. Lewis, Rachel E. Pollard, Chloe J. Peach, Badr Sokrat, Gokul Sriman Thanigai Arasu, Tracy Chiu, Dane D. Jensen, Nestor Nivardo Jiménez-Vargas, Abby Mocherniak, Lucas T. Parreiras‐e‐Silva, Michel Bouvier, Matthew Bogyo, , Nigel W. Bunnett

This study shows that targeting protease-activated receptor 2 (PAR2) signaling in organelles using nanomedicines provides sustained analgesia in preclinical models of inflammatory bowel disease.

Proceedings of the National Academy of Sciences · Oct 7, 2025Peer-reviewedPhysiology

Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity reveals structural factors responsible for differences in amino acid preferences between peptide-based substrates and covalent inhibitors.

Laura E. de Vries, Mateo I. Sanchez, Katarzyna Groborz, Laurie Kuppens, Marcin Poreba, Christine Lehmann, Fang Yuan, Shirin Arastu-Kapur, Martin Horn, Michael Mares, Matthew Bogyo, Marcin Drag, Edgar Deu

The paper characterizes P. falciparum DPAP3 specificity and identifies structural factors causing differences in amino acid preferences between peptide substrates and covalent inhibitors.

bioRxiv · Aug 10, 2018 · PreprintBiochemistry